✨ Your Portfolio is fetched and updated from zerodha.
Micro
Market Cap
₹931 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
931 Cr
PE
PE
-
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
7.36
ROCE (%)
ROCE (%)
7.27
Div Yield (%)
Div Yield (%)
-
Sales
Sales
363 Cr
OPM (%)
OPM (%)
3.30 %
Debt to Equity
Debt to Equity
-
About
Bharat Parenterals is in the Miscellaneous sector with a M.cap of 931.00 Cr and a PE r… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Bharat Parenterals Ltd. Business

Bharat Parenterals Limited specializes in manufacturing pharmaceutical formulations for domestic and international markets, aiming to become a leading company by providing high-quality products meeting customer and regulatory standards.

Bharat Parenterals major competitors are Wanbury, Anuh Pharma, Kwality Pharma, Lincoln Pharma, Ind-Swift Lab., Sakar Healthcare, Shivalik Rasayan.
Market Cap of Bharat Parenterals is ₹951 Crs.
While the median market cap of its peers are ₹875 Crs.

Bharat Parenterals seems to be less financially stable compared to its competitors.
Altman Z score of Bharat Parenterals is 3.11 and is ranked 7 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Jul Jun Sep Dec
Investor Presentation Jul Mar Dec
Conference Call Mar
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material